Association of SLC12A5 expression with patient’s clinico-pathological features in ovarian carcinomas
| SLC12A5 protein | ||||
| All cases | Low expression | High expression | P value* | |
| Age at surgery (years) | 0.565 | |||
| ≤51.4 † | 74 | 48 (65%) | 26 (35%) | |
| >51.4 | 73 | 44 (60%) | 29 (40%) | |
| Histological type | 0.414 | |||
| Serous | 96 | 63 (66%) | 33 (34%) | |
| Mucinous | 17 | 11 (65%) | 6 (35%) | |
| Others‡ | 34 | 18 (53%) | 16 (47%) | |
| Histological grade (Silveberg) | 0.009 | |||
| G1 | 25 | 20 (80%) | 5 (20%) | |
| G2 | 87 | 57 (66%) | 30 (34%) | |
| G3 | 35 | 15 (43%) | 20 (57%) | |
| pT status | 0.023 | |||
| pT1 | 38 | 30 (79%) | 8 (21%) | |
| pT2 | 30 | 20 (67%) | 10 (33%) | |
| pT3 | 79 | 42 (53%) | 37 (47%) | |
| pN status | 0.001 | |||
| pN0 | 80 | 60 (75%) | 20 (25%) | |
| pN1 | 67 | 32 (48%) | 35 (52%) | |
| pM status | 0.003 | |||
| pMX | 126 | 85 (67%) | 41 (33%) | |
| pM1 | 21 | 7 (33%) | 14 (67%) | |
| FIGO stage | <0.001 | |||
| I | 25 | 22 (88%) | 3 (12%) | |
| II | 19 | 16 (84%) | 3 (16%) | |
| III | 82 | 47 (57%) | 35 (43%) | |
| IV | 21 | 7 (33%) | 14 (67%) | |
*Chi-square test.
†Mean age.
‡Endometrioid, clear cell and undifferentiated types.